Show simple item record

dc.contributor.authorBennett, Julia C
dc.contributor.authorHetrich, Marissa K
dc.contributor.authorGarcia Quesada, Maria
dc.contributor.authorSinkevitch, Jenna N
dc.contributor.authorDeloria Knoll, Maria
dc.contributor.authorFeikin, Daniel R
dc.contributor.authorZeger, Scott L
dc.contributor.authorKagucia, Eunice W
dc.contributor.authorCohen, Adam L
dc.contributor.authorAmpofo, Krow
dc.contributor.authorBrandileone, Maria-Cristina C
dc.contributor.authorBruden, Dana
dc.contributor.authorCamilli, Romina
dc.contributor.authorCastilla, Jesús
dc.contributor.authorChan, Guanhao
dc.contributor.authorCook, Heather
dc.contributor.authorCornick, Jennifer E
dc.contributor.authorDagan, Ron
dc.contributor.authorDalby, Tine
dc.contributor.authorDanis, Kostas
dc.contributor.authorde Miguel, Sara
dc.contributor.authorDe Wals, Philippe
dc.contributor.authorDesmet, Stefanie
dc.contributor.authorGeorgakopoulou, Theano
dc.contributor.authorGilkison, Charlotte
dc.contributor.authorGrgic-Vitek, Marta
dc.contributor.authorHammitt, Laura L
dc.contributor.authorHilty, Markus
dc.contributor.authorHo, Pak-Leung
dc.contributor.authorJayasinghe, Sanjay
dc.contributor.authorKellner, James D
dc.contributor.authorKleynhans, Jackie
dc.contributor.authorKnol, Mirjam J
dc.contributor.authorKozakova, Jana
dc.contributor.authorKristinsson, Karl G
dc.contributor.authorLadhani, Shamez N
dc.contributor.authorMacDonald, Laura
dc.contributor.authorMackenzie, Grant A
dc.contributor.authorMad'arová, Lucia
dc.contributor.authorMcGeer, Allison
dc.contributor.authorMereckiene, Jolita
dc.contributor.authorMorfeldt, Eva
dc.contributor.authorMungun, Tuya
dc.contributor.authorMuñoz-Almagro, Carmen
dc.contributor.authorNuorti, J Pekka
dc.contributor.authorParagi, Metka
dc.contributor.authorPilishvili, Tamara
dc.contributor.authorPuentes, Rodrigo
dc.contributor.authorSaha, Samir K
dc.contributor.authorSahu Khan, Aalisha
dc.contributor.authorSavrasova, Larisa
dc.contributor.authorScott, J Anthony
dc.contributor.authorSkoczyńska, Anna
dc.contributor.authorSuga, Shigeru
dc.contributor.authorvan der Linden, Mark
dc.contributor.authorVerani, Jennifer R
dc.contributor.authorvon Gottberg, Anne
dc.contributor.authorWinje, Brita A
dc.contributor.authorYildirim, Inci
dc.contributor.authorZerouali, Khalid
dc.contributor.authorHayford, Kyla
dc.contributor.authorThe Pserenade Team
dc.date.accessioned2021-06-23T09:55:29Z
dc.date.available2021-06-23T09:55:29Z
dc.date.issued2021-03-27
dc.date.submitted2021-06
dc.identifier.citationBennett JC, Hetrich MK, Garcia Quesada M, Sinkevitch JN, Deloria Knoll M, Feikin DR, Zeger SL, Kagucia EW, Cohen AL, Ampofo K, Brandileone MC, Bruden D, Camilli R, Castilla J, Chan G, Cook H, Cornick JE, Dagan R, Dalby T, Danis K, de Miguel S, De Wals P, Desmet S, Georgakopoulou T, Gilkison C, Grgic-Vitek M, Hammitt LL, Hilty M, Ho PL, Jayasinghe S, Kellner JD, Kleynhans J, Knol MJ, Kozakova J, Kristinsson KG, Ladhani SN, MacDonald L, Mackenzie GA, Mad'arová L, McGeer A, Mereckiene J, Morfeldt E, Mungun T, Muñoz-Almagro C, Nuorti JP, Paragi M, Pilishvili T, Puentes R, Saha SK, Sahu Khan A, Savrasova L, Scott JA, Skoczyńska A, Suga S, van der Linden M, Verani JR, von Gottberg A, Winje BA, Yildirim I, Zerouali K, Hayford K, The Pserenade Team. Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project. Microorganisms. 2021 Mar 27;9(4):696. doi: 10.3390/microorganisms9040696.en_US
dc.identifier.issn2076-2607
dc.identifier.pmid33801760
dc.identifier.doi10.3390/microorganisms9040696
dc.identifier.urihttp://hdl.handle.net/2336/621826
dc.descriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Downloaden_US
dc.description.abstractStreptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (IPD) globally before the introduction of pneumococcal conjugate vaccines (PCVs) containing ST1 antigen. The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project gathered ST1 IPD surveillance data from sites globally and aimed to estimate PCV10/13 impact on ST1 IPD incidence. We estimated ST1 IPD incidence rate ratios (IRRs) comparing the pre-PCV10/13 period to each post-PCV10/13 year by site using a Bayesian multi-level, mixed-effects Poisson regression and all-site IRRs using a linear mixed-effects regression (N = 45 sites). Following PCV10/13 introduction, the incidence rate (IR) of ST1 IPD declined among all ages. After six years of PCV10/13 use, the all-site IRR was 0.05 (95% credibility interval 0.04-0.06) for all ages, 0.05 (0.04-0.05) for <5 years of age, 0.08 (0.06-0.09) for 5-17 years, 0.06 (0.05-0.08) for 18-49 years, 0.06 (0.05-0.07) for 50-64 years, and 0.05 (0.04-0.06) for ≥65 years. PCV10/13 use in infant immunization programs was followed by a 95% reduction in ST1 IPD in all ages after approximately 6 years. Limited data availability from the highest ST1 disease burden countries using a 3+0 schedule constrains generalizability and data from these settings are needed.en_US
dc.description.sponsorshipBill and Melinda Gates Foundation as part of theWorld Health Organization Pneumococcal Vaccines Technical Coordination Projecten_US
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.relation.urlhttps://www.mdpi.com/2076-2607/9/4/696en_US
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066231/en_US
dc.subjectinvasive pneumococcal diseaseen_US
dc.subjectpneumococcal conjugate vaccinesen_US
dc.subjectserotypesen_US
dc.subjectvaccine impacten_US
dc.subjectBakteríusjúkdómaren_US
dc.subjectPneumókokkaren_US
dc.subjectBólusetningaren_US
dc.subject.meshPneumococcal Infectionsen_US
dc.subject.meshVaccines, Conjugateen_US
dc.titleChanges in Invasive Pneumococcal Disease Caused by Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project.en_US
dc.typeArticleen_US
dc.contributor.department1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. 2Independent Consultant, 1296 Coppet, Switzerland. 3KEMRI-Wellcome Trust Research Programme, Epidemiology and Demography Department, Centre for Geographic Medicine-Coast, P.O. Box 230-80108, Kilifi, Kenya. 4World Health Organization, 1202 Geneva, Switzerland. 5Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA. 6National Laboratory for Meningitis and Pneumococcal Infections, Center of Bacteriology, Institute Adolfo Lutz (IAL), São Paulo 01246-902, Brazil. 7Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK 99508, USA. 8Department of Infectious Diseases, Italian National Institute of Health (Istituto Superiore di Sanità, ISS), 00161 Rome, Italy. 9CIBER Epidemiología y Salud Pública (CIBERESP), 28029 Madrid, Spain. 10Instituto de Salud Pública de Navarra-IdiSNA, 31003 Pamplona, Navarra, Spain. 11Singapore Ministry of Health, Communicable Diseases Division, Singapore 308442, Singapore. 12Centre for Disease Control, Department of Health and Community Services, Darwin, NT 8000, Australia. 13Institute of Infection, Veterinary & Ecological Sciences, University of Liverpool, Liverpool CH64 7TE, UK. 14Malawi-Liverpool-Wellcome Trust Clinical Research Programme, P.O. Box 30096, Chichiri, Blantyre 3, Malawi. 15Faculty of Health Sciences, Ben-Gurion University of the Negev, 8410501 Beer-Sheva, Israel. 16Bacteria, Parasites and Fungi, Statens Serum Institut, DK-2300 Copenhagen, Denmark. 17Santé Publique France, the French National Public Health Agency, Saint Maurice CEDEX, 94415 Paris, France. 18Epidemiology Department, Dirección General de Salud Pública, 28009 Madrid, Spain. 19Department of Social and Preventive Medicine, Laval University, Québec, QC G1V 0A6, Canada. 20Department of Microbiology, Immunology and Transplantation, KU Leuven, BE-3000 Leuven, Belgium. 21National Reference Centre for Streptococcus Pneumoniae, University Hospitals Leuven, 3000 Leuven, Belgium. 22National Public Health Organisation, 15123 Athens, Greece. 23Epidemiology Team, Institute of Environmental Science and Research, Porirua, 5240 Wellington, New Zealand. 24Communicable Diseases Centre, National Institute of Public Health, 1000 Ljubljana, Slovenia. 25Swiss National Reference Centre for Invasive Pneumococci, Institute for Infectious Diseases, University of Bern, 3012 Bern, Switzerland. 26Department of Microbiology and Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong, China. 27National Centre for Immunisation Research and Surveillance and Discipline of Child and Adolescent Health, Children's Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Westmead, NSW 2145, Australia. 28Department of Pediatrics, University of Calgary, and Alberta Health Services, Calgary, AB T3B 6A8, Canada. 29Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, 2192 Johannesburg, South Africa. 30School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, 2000 Johannesburg, South Africa. 31National Institute for Public Health and the Environment, 3721 MA Bilthoven, The Netherlands. 32National Institute of Public Health (NIPH), 100 42, Praha Czech Republic. 33Department of Clinical Microbiology, Landspitali-The National University Hospital, Hringbraut, 101 Reykjavik, Iceland. 34Immunisation and Countermeasures Division, Public Health England, London NW9 5EQ, UK. 35Public Health Scotland, Glasgow G2 6QE, UK. 36Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel St, London, WC1E 7HT, UK. 37Medical Research Council Unit the Gambia atLondon School of Hygiene & Tropical Medicine, P.O. Box 273, Banjul, The Gambia. 38New Vaccines Group, Murdoch Children's Research Institute, Parkville, Melbourne, 3052, Victoria, Australia. 39National Reference Centre for Pneumococcal and Haemophilus Diseases, Regional Authority of Public Health, 975 56 Banská Bystrica, Slovakia. 40Toronto Invasive Bacterial Diseases Network, Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada. 41HSE Health Protection Surveillance Centre, Mountjoy, Dublin D01 A4A3, Ireland. 42Department of Microbiology, Public Health Agency of Sweden, 171 82 Solna, Sweden. 43National Center of Communicable Diseases (NCCD), Ministry of Health, Bayanzurkh District, Ulaanbaatar 13336, Mongolia. 44Medicine Department, Universitat Internacional de Catalunya, 08017 Barcelona, Spain. 45Molecular Microbiology Department, Hospital Sant Joan de Déu Research Institute, 08950 Esplugues de Llobregat, Barcelona, Spain. 46Department of Health Security, Finnish Institute for Health and Welfare, 00271 Helsinki, Finland. 47Health Sciences Unit, Faculty of Social Sciences, University of Tampere, 33100 Tampere, Finland. 48Centre for Medical Microbiology, National Laboratory of Health, Environment and Food, 2000 Maribor, Slovenia. 49National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. 50Instituto de Salud Pública de Chile, 7780050 Santiago, Santiago Metropolitan, Chile. 51Child Health Research Foundation, Dhaka 1207, Bangladesh. 52Ministry of Health and Medical Services, Suva, Fiji. 53Centre for Disease Prevention and Control of Latvia, 1005 Riga, Latvia. 54Doctoral Studies Department, Riga Stradinš University, 1007 Riga, Latvia. 55National Reference Centre for Bacterial Meningitis, National Medicines Institute, 00-725 Warsaw, Poland. 56Infectious Disease Center and Department of Clinical Research, National Hospital Organization Mie Hospital, Tsu, Mie 514-0125, Japan. 57National Reference Center for Streptococci, Department of Medical Microbiology, University Hospital RWTH Aachen, 52074 Aachen, Germany. 58Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH), Division of Global Health Protection (DGHP), Nairobi, Kenya. 59School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Braamfontein, Johannesburg 2000, South Africa. 60Department of Infection Control and Vaccine, Norwegian Institute of Public Health, 0456 Oslo, Norway. 61Department of Pediatrics, Yale New Haven Children's Hospital, New Haven, CT 06504, USA. 62Bacteriology-Virology and Hospital Hygiene Laboratory, Ibn Rochd University Hospital Centre, Casablanca 20250, Morocco. 63Department of Microbiology, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Casablanca 20000, Morocco.en_US
dc.identifier.journalMicroorganismsen_US
dc.rights.accessOpen Access - Opinn aðganguren_US
dc.departmentcodeBAC12
dc.source.journaltitleMicroorganisms
dc.source.volume9
dc.source.issue4
refterms.dateFOA2021-06-23T09:55:29Z
dc.source.countryInternational
dc.source.countrySwitzerland


Files in this item

Thumbnail
Name:
Changes in invasive ....pdf
Size:
1.725Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record